

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | piRNA metabolic process (GO:0034587) | 6.96037436 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.86556296 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.86556296 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.65497718 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.65497718 |
| 6 | regulation of meiosis I (GO:0060631) | 6.24608975 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.92628496 |
| 8 | cysteine metabolic process (GO:0006534) | 5.52764864 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50278149 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.22633340 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 5.21654998 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.13830495 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.13830495 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.13830495 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.11240152 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.03934281 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.02376483 |
| 18 | regulation of DNA methylation (GO:0044030) | 4.96032259 |
| 19 | tryptophan metabolic process (GO:0006568) | 4.92369419 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.91546617 |
| 21 | urea metabolic process (GO:0019627) | 4.86785567 |
| 22 | urea cycle (GO:0000050) | 4.86785567 |
| 23 | DNA methylation involved in gamete generation (GO:0043046) | 4.78057174 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 4.76142044 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 4.72160872 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 4.71255581 |
| 27 | glycine metabolic process (GO:0006544) | 4.62985223 |
| 28 | protein carboxylation (GO:0018214) | 4.60428309 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.60428309 |
| 30 | lysine metabolic process (GO:0006553) | 4.58481990 |
| 31 | lysine catabolic process (GO:0006554) | 4.58481990 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.57302521 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.56492634 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.52545902 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.51046684 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.50980213 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.41554790 |
| 38 | regulation of female gonad development (GO:2000194) | 4.40704196 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.35660941 |
| 40 | bile acid metabolic process (GO:0008206) | 4.35638737 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.33501370 |
| 42 | serine family amino acid biosynthetic process (GO:0009070) | 4.33152060 |
| 43 | serine family amino acid metabolic process (GO:0009069) | 4.31815691 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.27630049 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.25940193 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.24707742 |
| 47 | meiotic cell cycle (GO:0051321) | 4.22270747 |
| 48 | regulation of complement activation (GO:0030449) | 4.22073880 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.20018832 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.17769680 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.17769680 |
| 52 | valine metabolic process (GO:0006573) | 4.15815286 |
| 53 | gene silencing by RNA (GO:0031047) | 4.15775197 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 4.13286600 |
| 55 | macromolecular complex remodeling (GO:0034367) | 4.13286600 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 4.13286600 |
| 57 | tyrosine metabolic process (GO:0006570) | 4.11177920 |
| 58 | phospholipid efflux (GO:0033700) | 4.03803253 |
| 59 | iron-sulfur cluster assembly (GO:0016226) | 4.01823261 |
| 60 | metallo-sulfur cluster assembly (GO:0031163) | 4.01823261 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.97594393 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 3.95382847 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 3.91566442 |
| 64 | negative regulation of sterol transport (GO:0032372) | 3.91566442 |
| 65 | coenzyme catabolic process (GO:0009109) | 3.84306510 |
| 66 | bile acid and bile salt transport (GO:0015721) | 3.82579300 |
| 67 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81946680 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 3.81621114 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 3.79840966 |
| 70 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.79193496 |
| 71 | histone H2A acetylation (GO:0043968) | 3.78969464 |
| 72 | male meiosis I (GO:0007141) | 3.74229955 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 3.71338709 |
| 74 | protein kinase C signaling (GO:0070528) | 3.65389496 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 3.64339340 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.62621625 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 3.60571297 |
| 78 | ethanol oxidation (GO:0006069) | 3.60356141 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.58947138 |
| 80 | cholesterol efflux (GO:0033344) | 3.56883693 |
| 81 | carboxylic acid catabolic process (GO:0046395) | 3.55848960 |
| 82 | organic acid catabolic process (GO:0016054) | 3.55848960 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.52831385 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 3.52028394 |
| 85 | amine catabolic process (GO:0009310) | 3.52028394 |
| 86 | glutamate metabolic process (GO:0006536) | 3.51794526 |
| 87 | aldehyde catabolic process (GO:0046185) | 3.44474763 |
| 88 | fatty acid beta-oxidation (GO:0006635) | 3.43920695 |
| 89 | cellular glucuronidation (GO:0052695) | 3.43237218 |
| 90 | fatty acid oxidation (GO:0019395) | 3.41681806 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.40885896 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.40885896 |
| 93 | regulation of histone H3-K9 methylation (GO:0051570) | 3.37925176 |
| 94 | L-serine metabolic process (GO:0006563) | 3.37110201 |
| 95 | monocarboxylic acid catabolic process (GO:0072329) | 3.36362387 |
| 96 | cholesterol homeostasis (GO:0042632) | 3.35935741 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.35185801 |
| 98 | one-carbon metabolic process (GO:0006730) | 3.35154606 |
| 99 | fatty acid catabolic process (GO:0009062) | 3.33421394 |
| 100 | lipid oxidation (GO:0034440) | 3.32847156 |
| 101 | synapsis (GO:0007129) | 3.32566780 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.32563655 |
| 103 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.31958366 |
| 104 | branched-chain amino acid catabolic process (GO:0009083) | 3.31775364 |
| 105 | regulation of acrosome reaction (GO:0060046) | 3.31315451 |
| 106 | sterol homeostasis (GO:0055092) | 3.29824590 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 3.29063969 |
| 108 | complement activation, classical pathway (GO:0006958) | 3.27939956 |
| 109 | multicellular organism reproduction (GO:0032504) | 3.27912691 |
| 110 | negative regulation of lipase activity (GO:0060192) | 3.27644851 |
| 111 | sister chromatid cohesion (GO:0007062) | 3.24892041 |
| 112 | CENP-A containing nucleosome assembly (GO:0034080) | 3.24201963 |
| 113 | mitotic chromosome condensation (GO:0007076) | 3.23954504 |
| 114 | blood coagulation, intrinsic pathway (GO:0007597) | 3.23833188 |
| 115 | arginine metabolic process (GO:0006525) | 3.23321056 |
| 116 | response to nitrosative stress (GO:0051409) | 3.23231383 |
| 117 | low-density lipoprotein particle remodeling (GO:0034374) | 3.23101295 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.22892960 |
| 119 | branched-chain amino acid metabolic process (GO:0009081) | 3.22592674 |
| 120 | cofactor catabolic process (GO:0051187) | 3.22205206 |
| 121 | carnitine metabolic process (GO:0009437) | 3.21862168 |
| 122 | drug catabolic process (GO:0042737) | 3.21847460 |
| 123 | meiosis I (GO:0007127) | 3.15040052 |
| 124 | DNA alkylation (GO:0006305) | 3.14677152 |
| 125 | DNA methylation (GO:0006306) | 3.14677152 |
| 126 | synaptonemal complex assembly (GO:0007130) | 3.14177130 |
| 127 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 3.12930508 |
| 128 | chromatin remodeling at centromere (GO:0031055) | 3.04047987 |
| 129 | pyrimidine dimer repair (GO:0006290) | 3.01252660 |
| 130 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.00800612 |
| 131 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.00696975 |
| 132 | meiotic nuclear division (GO:0007126) | 3.00410990 |
| 133 | chromosome organization involved in meiosis (GO:0070192) | 2.97823212 |
| 134 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.97050828 |
| 135 | female gamete generation (GO:0007292) | 2.96676546 |
| 136 | protein localization to chromosome, centromeric region (GO:0071459) | 2.96619377 |
| 137 | protein localization to kinetochore (GO:0034501) | 2.95496435 |
| 138 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.94489691 |
| 139 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.94489691 |
| 140 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.93600943 |
| 141 | ubiquinone biosynthetic process (GO:0006744) | 2.92150725 |
| 142 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.90767479 |
| 143 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89468443 |
| 144 | microtubule severing (GO:0051013) | 2.88442289 |
| 145 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.88206070 |
| 146 | spermatid nucleus differentiation (GO:0007289) | 2.87024768 |
| 147 | positive regulation of humoral immune response (GO:0002922) | 2.86751773 |
| 148 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.85033060 |
| 149 | negative regulation of reproductive process (GO:2000242) | 2.84307760 |
| 150 | base-excision repair, AP site formation (GO:0006285) | 2.82939962 |
| 151 | retinal cone cell development (GO:0046549) | 2.82930594 |
| 152 | male meiosis (GO:0007140) | 2.81351561 |
| 153 | neural tube formation (GO:0001841) | 2.80191638 |
| 154 | oocyte development (GO:0048599) | 2.79732821 |
| 155 | resolution of meiotic recombination intermediates (GO:0000712) | 2.79345090 |
| 156 | protein localization to chromosome (GO:0034502) | 2.78918095 |
| 157 | protein prenylation (GO:0018342) | 2.78296817 |
| 158 | prenylation (GO:0097354) | 2.78296817 |
| 159 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.78222203 |
| 160 | base-excision repair (GO:0006284) | 2.75866425 |
| 161 | seminiferous tubule development (GO:0072520) | 2.72560929 |
| 162 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.70791237 |
| 163 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.70791237 |
| 164 | meiotic cell cycle process (GO:1903046) | 2.68015909 |
| 165 | binding of sperm to zona pellucida (GO:0007339) | 2.66950543 |
| 166 | histone H3-K9 demethylation (GO:0033169) | 2.66849598 |
| 167 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.66025883 |
| 168 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.65124882 |
| 169 | positive regulation of gastrulation (GO:2000543) | 2.64837869 |
| 170 | synaptonemal complex organization (GO:0070193) | 2.64472622 |
| 171 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.64201050 |
| 172 | telomere maintenance via recombination (GO:0000722) | 2.63511633 |
| 173 | DNA replication-independent nucleosome organization (GO:0034724) | 2.63033285 |
| 174 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.63033285 |
| 175 | centriole replication (GO:0007099) | 2.62958399 |
| 176 | mitotic recombination (GO:0006312) | 2.62660552 |
| 177 | histone exchange (GO:0043486) | 2.60240006 |
| 178 | positive regulation of granulocyte differentiation (GO:0030854) | 2.59929292 |
| 179 | ubiquinone metabolic process (GO:0006743) | 2.59678227 |
| 180 | gene silencing (GO:0016458) | 2.58500911 |
| 181 | GMP metabolic process (GO:0046037) | 2.57324865 |
| 182 | translesion synthesis (GO:0019985) | 2.56881562 |
| 183 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.55774705 |
| 184 | DNA methylation or demethylation (GO:0044728) | 2.54451502 |
| 185 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.52575939 |
| 186 | viral protein processing (GO:0019082) | 2.51246775 |
| 187 | DNA replication checkpoint (GO:0000076) | 2.48903651 |
| 188 | N-terminal protein amino acid acetylation (GO:0006474) | 2.48088526 |
| 189 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.46767404 |
| 190 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.45447772 |
| 191 | quinone biosynthetic process (GO:1901663) | 2.43742073 |
| 192 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.43424762 |
| 193 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.43424762 |
| 194 | histone H3-K9 methylation (GO:0051567) | 2.43285075 |
| 195 | regulation of hypersensitivity (GO:0002883) | 2.43074205 |
| 196 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.40126105 |
| 197 | gonadal mesoderm development (GO:0007506) | 2.38665158 |
| 198 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.37990554 |
| 199 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.36443887 |
| 200 | DNA strand elongation (GO:0022616) | 2.36443035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.28943057 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50878416 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.80825023 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.02548156 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.86116153 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.61353088 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.51633291 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47278734 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.21906370 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.08484043 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.45939934 |
| 12 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.31581090 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.83420900 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.69779494 |
| 15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.66010533 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.63751027 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.41881784 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.38482901 |
| 19 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.31563482 |
| 20 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27623910 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.22544136 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09520750 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04960861 |
| 24 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.04663257 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.04233041 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.03579188 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02615024 |
| 28 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 2.02306677 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.92955980 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.92169970 |
| 31 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87760702 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84600908 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84209048 |
| 34 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.80486705 |
| 35 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.79351446 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.79100101 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73265921 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.70916355 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67837309 |
| 40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.67324732 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.67101802 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.66416916 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62899383 |
| 44 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.60915294 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.59642399 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58052439 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.46960883 |
| 48 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45651218 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.32039680 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31365279 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30110748 |
| 52 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28309818 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27721597 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27483486 |
| 55 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27356149 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27146427 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24822217 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.23996777 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21981893 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.21538671 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21321752 |
| 62 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.20964797 |
| 63 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19452187 |
| 64 | GATA3_26560356_Chip-Seq_TH1_Human | 1.19203053 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.19151947 |
| 66 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.17683556 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17400812 |
| 68 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17194266 |
| 69 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15099034 |
| 70 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14267317 |
| 71 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12319929 |
| 72 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.12168724 |
| 73 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.12049713 |
| 74 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.10625853 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10161999 |
| 76 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09527518 |
| 77 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08925842 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07564701 |
| 79 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07087733 |
| 80 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.06645568 |
| 81 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06286240 |
| 82 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05175009 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04992123 |
| 84 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.03709116 |
| 85 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03003595 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02388297 |
| 87 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02094776 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.01659044 |
| 89 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00916347 |
| 90 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.99677386 |
| 91 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98877842 |
| 92 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97976138 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96467778 |
| 94 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.95956524 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95528295 |
| 96 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.95509361 |
| 97 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95484215 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95462107 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93852123 |
| 100 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93728923 |
| 101 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.93643875 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92679846 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92228342 |
| 104 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91598283 |
| 105 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90220533 |
| 106 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88961952 |
| 107 | P300_27268052_Chip-Seq_Bcells_Human | 0.88955631 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88452719 |
| 109 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88286925 |
| 110 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.88215118 |
| 111 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87835322 |
| 112 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87508638 |
| 113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.87190153 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87012607 |
| 115 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86828896 |
| 116 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.86478885 |
| 117 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85556531 |
| 118 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.82889674 |
| 119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82161509 |
| 120 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82019029 |
| 121 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81290275 |
| 122 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80657255 |
| 123 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.80499621 |
| 124 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.80180800 |
| 125 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.79370815 |
| 126 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.79217502 |
| 127 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.78606015 |
| 128 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.77894994 |
| 129 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77313829 |
| 130 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.76943121 |
| 131 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76897422 |
| 132 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.76703581 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76251628 |
| 134 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75825625 |
| 135 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75132767 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.74202095 |
| 137 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.73779344 |
| 138 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.73779151 |
| 139 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.72776997 |
| 140 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.72734782 |
| 141 | MAF_26560356_Chip-Seq_TH1_Human | 0.71391896 |
| 142 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71236578 |
| 143 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.71118554 |
| 144 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.70253679 |
| 145 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69653676 |
| 146 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.69646026 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69134453 |
| 148 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.67976577 |
| 149 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.67550143 |
| 150 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67541475 |
| 151 | ATF3_27146783_Chip-Seq_COLON_Human | 0.66808759 |
| 152 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.66763412 |
| 153 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.66109842 |
| 154 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.66082191 |
| 155 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.64716556 |
| 156 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.64497809 |
| 157 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63970760 |
| 158 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.63954418 |
| 159 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.63683667 |
| 160 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.63508208 |
| 161 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.63101048 |
| 162 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.62949276 |
| 163 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.60678968 |
| 164 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.60414132 |
| 165 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60280068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.97052967 |
| 2 | MP0005360_urolithiasis | 6.27133337 |
| 3 | MP0005365_abnormal_bile_salt | 6.11572527 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.56198668 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.23428532 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.71258310 |
| 7 | MP0003252_abnormal_bile_duct | 3.65606740 |
| 8 | MP0005083_abnormal_biliary_tract | 3.49687373 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.29569233 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.21402802 |
| 11 | MP0009840_abnormal_foam_cell | 3.14708612 |
| 12 | MP0006292_abnormal_olfactory_placode | 3.07041576 |
| 13 | MP0008058_abnormal_DNA_repair | 3.02999738 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.71615151 |
| 15 | MP0003195_calcinosis | 2.55371935 |
| 16 | MP0005332_abnormal_amino_acid | 2.54958554 |
| 17 | MP0008789_abnormal_olfactory_epithelium | 2.50743821 |
| 18 | MP0010094_abnormal_chromosome_stability | 2.46075525 |
| 19 | MP0005394_taste/olfaction_phenotype | 2.43588544 |
| 20 | MP0005499_abnormal_olfactory_system | 2.43588544 |
| 21 | MP0003868_abnormal_feces_composition | 2.28764606 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.25782211 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.22902020 |
| 24 | MP0008877_abnormal_DNA_methylation | 2.22331965 |
| 25 | MP0000609_abnormal_liver_physiology | 2.21832384 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.99980324 |
| 27 | MP0005220_abnormal_exocrine_pancreas | 1.99519622 |
| 28 | MP0001929_abnormal_gametogenesis | 1.92641359 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.90596155 |
| 30 | MP0008260_abnormal_autophagy | 1.90432329 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.88333044 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.80743379 |
| 33 | MP0003077_abnormal_cell_cycle | 1.80342036 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.78580585 |
| 35 | MP0003111_abnormal_nucleus_morphology | 1.75075339 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.73356341 |
| 37 | MP0002210_abnormal_sex_determination | 1.72766027 |
| 38 | MP0001764_abnormal_homeostasis | 1.69232387 |
| 39 | MP0008995_early_reproductive_senescence | 1.60190111 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.57876546 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.52740044 |
| 42 | MP0000653_abnormal_sex_gland | 1.42089277 |
| 43 | MP0000598_abnormal_liver_morphology | 1.41306994 |
| 44 | MP0003186_abnormal_redox_activity | 1.40780069 |
| 45 | MP0002160_abnormal_reproductive_system | 1.40196775 |
| 46 | MP0003699_abnormal_female_reproductive | 1.39597446 |
| 47 | MP0004957_abnormal_blastocyst_morpholog | 1.38770159 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.38007347 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.37384630 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34110765 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.32896356 |
| 52 | MP0001145_abnormal_male_reproductive | 1.32356431 |
| 53 | MP0003786_premature_aging | 1.32149097 |
| 54 | MP0003698_abnormal_male_reproductive | 1.31434717 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.27495117 |
| 56 | MP0001873_stomach_inflammation | 1.25327435 |
| 57 | MP0008057_abnormal_DNA_replication | 1.23441906 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.21962801 |
| 59 | MP0008932_abnormal_embryonic_tissue | 1.21528469 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.21486700 |
| 61 | MP0005670_abnormal_white_adipose | 1.18199288 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.17484299 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 1.16234045 |
| 64 | MP0002398_abnormal_bone_marrow | 1.14029284 |
| 65 | MP0002722_abnormal_immune_system | 1.11894854 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 1.11712483 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.11061979 |
| 68 | MP0009278_abnormal_bone_marrow | 1.09199262 |
| 69 | MP0000049_abnormal_middle_ear | 1.09094435 |
| 70 | MP0002161_abnormal_fertility/fecundity | 1.08559620 |
| 71 | MP0001800_abnormal_humoral_immune | 1.08057951 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 1.07521440 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.07366436 |
| 74 | MP0009763_increased_sensitivity_to | 1.06347507 |
| 75 | MP0009697_abnormal_copulation | 1.05211031 |
| 76 | MP0008469_abnormal_protein_level | 1.04053096 |
| 77 | MP0002132_abnormal_respiratory_system | 1.02747742 |
| 78 | MP0005410_abnormal_fertilization | 1.02443488 |
| 79 | MP0002420_abnormal_adaptive_immunity | 1.01598591 |
| 80 | MP0001545_abnormal_hematopoietic_system | 1.01298996 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.01298996 |
| 82 | MP0005647_abnormal_sex_gland | 0.98231980 |
| 83 | MP0001819_abnormal_immune_cell | 0.97760047 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.95479503 |
| 85 | MP0005389_reproductive_system_phenotype | 0.95372648 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.94923702 |
| 87 | MP0001119_abnormal_female_reproductive | 0.92370862 |
| 88 | MP0001730_embryonic_growth_arrest | 0.92016479 |
| 89 | MP0002723_abnormal_immune_serum | 0.91855963 |
| 90 | MP0005671_abnormal_response_to | 0.91575232 |
| 91 | MP0001944_abnormal_pancreas_morphology | 0.91279068 |
| 92 | MP0005387_immune_system_phenotype | 0.90774217 |
| 93 | MP0001790_abnormal_immune_system | 0.90774217 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.88268543 |
| 95 | MP0000716_abnormal_immune_system | 0.87961813 |
| 96 | MP0005334_abnormal_fat_pad | 0.87296756 |
| 97 | MP0004381_abnormal_hair_follicle | 0.86804977 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.86141571 |
| 99 | MP0009764_decreased_sensitivity_to | 0.85715407 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.85131015 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.83783552 |
| 102 | MP0001835_abnormal_antigen_presentation | 0.83290306 |
| 103 | MP0004142_abnormal_muscle_tone | 0.81864073 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.80987568 |
| 105 | MP0005464_abnormal_platelet_physiology | 0.80390901 |
| 106 | MP0002928_abnormal_bile_duct | 0.79072560 |
| 107 | MP0001756_abnormal_urination | 0.78776832 |
| 108 | MP0005408_hypopigmentation | 0.78381542 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.78142687 |
| 110 | MP0005448_abnormal_energy_balance | 0.77571101 |
| 111 | MP0010352_gastrointestinal_tract_polyps | 0.77312479 |
| 112 | MP0010368_abnormal_lymphatic_system | 0.76872511 |
| 113 | MP0005451_abnormal_body_composition | 0.76592263 |
| 114 | MP0002452_abnormal_antigen_presenting | 0.76196037 |
| 115 | MP0002095_abnormal_skin_pigmentation | 0.76128423 |
| 116 | MP0005646_abnormal_pituitary_gland | 0.75755141 |
| 117 | MP0003011_delayed_dark_adaptation | 0.75126465 |
| 118 | MP0002429_abnormal_blood_cell | 0.73804327 |
| 119 | MP0002971_abnormal_brown_adipose | 0.72726923 |
| 120 | MP0003121_genomic_imprinting | 0.72232536 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.70818473 |
| 122 | MP0000313_abnormal_cell_death | 0.70524225 |
| 123 | MP0000604_amyloidosis | 0.70370581 |
| 124 | MP0004130_abnormal_muscle_cell | 0.70344197 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.70135626 |
| 126 | MP0002102_abnormal_ear_morphology | 0.68301641 |
| 127 | MP0001853_heart_inflammation | 0.68295040 |
| 128 | MP0002249_abnormal_larynx_morphology | 0.68215495 |
| 129 | MP0005266_abnormal_metabolism | 0.66585854 |
| 130 | MP0001661_extended_life_span | 0.65612862 |
| 131 | MP0002163_abnormal_gland_morphology | 0.64360007 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.64163185 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.63940969 |
| 134 | MP0003300_gastrointestinal_ulcer | 0.63003879 |
| 135 | MP0009672_abnormal_birth_weight | 0.63001878 |
| 136 | MP0003959_abnormal_lean_body | 0.62601898 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.62461854 |
| 138 | MP0003953_abnormal_hormone_level | 0.62142114 |
| 139 | MP0003724_increased_susceptibility_to | 0.61737208 |
| 140 | MP0005535_abnormal_body_temperature | 0.61618942 |
| 141 | MP0003436_decreased_susceptibility_to | 0.60437337 |
| 142 | MP0002970_abnormal_white_adipose | 0.59058371 |
| 143 | MP0000685_abnormal_immune_system | 0.58982880 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.58744248 |
| 145 | MP0002136_abnormal_kidney_physiology | 0.56840152 |
| 146 | MP0002876_abnormal_thyroid_physiology | 0.53360389 |
| 147 | MP0008873_increased_physiological_sensi | 0.52007921 |
| 148 | MP0004147_increased_porphyrin_level | 0.50687041 |
| 149 | MP0005058_abnormal_lysosome_morphology | 0.49749420 |
| 150 | MP0006035_abnormal_mitochondrial_morpho | 0.46139441 |
| 151 | MP0005023_abnormal_wound_healing | 0.45094415 |
| 152 | MP0002877_abnormal_melanocyte_morpholog | 0.44936118 |
| 153 | MP0002135_abnormal_kidney_morphology | 0.44476611 |
| 154 | MP0010155_abnormal_intestine_physiology | 0.43348061 |
| 155 | MP0009115_abnormal_fat_cell | 0.42825383 |
| 156 | MP0004782_abnormal_surfactant_physiolog | 0.40357646 |
| 157 | MP0003693_abnormal_embryo_hatching | 0.39108834 |
| 158 | MP0005375_adipose_tissue_phenotype | 0.39061445 |
| 159 | MP0003943_abnormal_hepatobiliary_system | 0.39040536 |
| 160 | MP0005187_abnormal_penis_morphology | 0.37574602 |
| 161 | MP0004947_skin_inflammation | 0.37339592 |
| 162 | MP0005395_other_phenotype | 0.37226876 |
| 163 | MP0001243_abnormal_dermal_layer | 0.36520044 |
| 164 | MP0000689_abnormal_spleen_morphology | 0.36092131 |
| 165 | MP0002837_dystrophic_cardiac_calcinosis | 0.35593294 |
| 166 | MP0005025_abnormal_response_to | 0.35519264 |
| 167 | MP0004043_abnormal_pH_regulation | 0.33213998 |
| 168 | MP0009785_altered_susceptibility_to | 0.32964621 |
| 169 | MP0002166_altered_tumor_susceptibility | 0.32812842 |
| 170 | MP0003718_maternal_effect | 0.32377765 |
| 171 | MP0002269_muscular_atrophy | 0.31941515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.91019011 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.07184635 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.01400269 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.95044789 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.48849829 |
| 6 | Xanthomatosis (HP:0000991) | 5.32714503 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.28025469 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.95519970 |
| 9 | Complement deficiency (HP:0004431) | 4.56008682 |
| 10 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.53297131 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.50009176 |
| 12 | Ketosis (HP:0001946) | 4.40635980 |
| 13 | Hyperammonemia (HP:0001987) | 4.36905931 |
| 14 | Hyperglycinemia (HP:0002154) | 4.19929621 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.16965183 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.07168270 |
| 17 | Chromsome breakage (HP:0040012) | 4.06804224 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 4.05460057 |
| 19 | Fat malabsorption (HP:0002630) | 4.05180248 |
| 20 | Hyperglycinuria (HP:0003108) | 3.97374650 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.92384159 |
| 22 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.86694515 |
| 23 | Joint hemorrhage (HP:0005261) | 3.86640987 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.82242703 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82242703 |
| 26 | B lymphocytopenia (HP:0010976) | 3.78505703 |
| 27 | Osteomalacia (HP:0002749) | 3.71860186 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.67808681 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63364094 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.57964302 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.56040819 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.55555161 |
| 33 | Hypoglycemic seizures (HP:0002173) | 3.53802135 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.51543259 |
| 35 | Epidermoid cyst (HP:0200040) | 3.51369737 |
| 36 | Ketoacidosis (HP:0001993) | 3.48226128 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 3.48134230 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.45300194 |
| 39 | Abnormality of B cell number (HP:0010975) | 3.40696825 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.37217866 |
| 41 | Abnormality of complement system (HP:0005339) | 3.27382720 |
| 42 | Steatorrhea (HP:0002570) | 3.21824536 |
| 43 | Abnormality of DNA repair (HP:0003254) | 3.16948917 |
| 44 | Retinal dysplasia (HP:0007973) | 3.15113964 |
| 45 | Gout (HP:0001997) | 3.10490377 |
| 46 | Generalized aminoaciduria (HP:0002909) | 3.09851577 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09569932 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 3.07540470 |
| 49 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.05436268 |
| 50 | Hypoplasia of the uterus (HP:0000013) | 3.03621318 |
| 51 | Late onset (HP:0003584) | 3.01861402 |
| 52 | Abnormality of the preputium (HP:0100587) | 2.98975013 |
| 53 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.98078818 |
| 54 | Premature ovarian failure (HP:0008209) | 2.97813277 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.95938583 |
| 56 | Microvesicular hepatic steatosis (HP:0001414) | 2.94448915 |
| 57 | Hypercholesterolemia (HP:0003124) | 2.94201230 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.89429302 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.89429302 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.88998268 |
| 61 | Abnormality of purine metabolism (HP:0004352) | 2.86577317 |
| 62 | Reticulocytopenia (HP:0001896) | 2.77421930 |
| 63 | Metabolic acidosis (HP:0001942) | 2.74716982 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.74437446 |
| 65 | Combined immunodeficiency (HP:0005387) | 2.67744767 |
| 66 | Abnormality of the renal collecting system (HP:0004742) | 2.63613220 |
| 67 | Stomatitis (HP:0010280) | 2.61012006 |
| 68 | Severe combined immunodeficiency (HP:0004430) | 2.60154738 |
| 69 | Impulsivity (HP:0100710) | 2.59613551 |
| 70 | Gonadotropin excess (HP:0000837) | 2.57007772 |
| 71 | Abnormality of the ileum (HP:0001549) | 2.55715886 |
| 72 | Myocardial infarction (HP:0001658) | 2.54825325 |
| 73 | Tubulointerstitial nephritis (HP:0001970) | 2.53863016 |
| 74 | Hyperglycemia (HP:0003074) | 2.53049319 |
| 75 | Lethargy (HP:0001254) | 2.52251794 |
| 76 | Abnormality of chromosome stability (HP:0003220) | 2.51946143 |
| 77 | Hypophosphatemic rickets (HP:0004912) | 2.50618163 |
| 78 | Symptomatic seizures (HP:0011145) | 2.50292857 |
| 79 | Abnormality of the labia minora (HP:0012880) | 2.49887672 |
| 80 | Meckel diverticulum (HP:0002245) | 2.49323467 |
| 81 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.45742853 |
| 82 | Clubbing of toes (HP:0100760) | 2.44579232 |
| 83 | Facial hemangioma (HP:0000329) | 2.43800055 |
| 84 | Skin nodule (HP:0200036) | 2.42787546 |
| 85 | Duplicated collecting system (HP:0000081) | 2.41898462 |
| 86 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.40938902 |
| 87 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.40938902 |
| 88 | Pancreatitis (HP:0001733) | 2.37445049 |
| 89 | Cholecystitis (HP:0001082) | 2.36679805 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.36679805 |
| 91 | Opisthotonus (HP:0002179) | 2.33581530 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.32194232 |
| 93 | Hypergonadotropic hypogonadism (HP:0000815) | 2.29653133 |
| 94 | Systemic lupus erythematosus (HP:0002725) | 2.29367200 |
| 95 | Myelodysplasia (HP:0002863) | 2.28420006 |
| 96 | Neutropenia (HP:0001875) | 2.27545658 |
| 97 | Irritability (HP:0000737) | 2.23985312 |
| 98 | Spastic diplegia (HP:0001264) | 2.23493142 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 2.21473660 |
| 100 | Medial flaring of the eyebrow (HP:0010747) | 2.21121143 |
| 101 | Severe visual impairment (HP:0001141) | 2.20924850 |
| 102 | Abnormality of male internal genitalia (HP:0000022) | 2.19419879 |
| 103 | Malnutrition (HP:0004395) | 2.19365798 |
| 104 | Spontaneous abortion (HP:0005268) | 2.18595747 |
| 105 | IgG deficiency (HP:0004315) | 2.18224118 |
| 106 | Hypochromic microcytic anemia (HP:0004840) | 2.17357341 |
| 107 | Small intestinal stenosis (HP:0012848) | 2.16344393 |
| 108 | Duodenal stenosis (HP:0100867) | 2.16344393 |
| 109 | Abnormal number of erythroid precursors (HP:0012131) | 2.16198122 |
| 110 | Brushfield spots (HP:0001088) | 2.15308272 |
| 111 | Acanthocytosis (HP:0001927) | 2.13496421 |
| 112 | Abnormality of lateral ventricle (HP:0030047) | 2.12889000 |
| 113 | Esophageal varix (HP:0002040) | 2.12532217 |
| 114 | Menorrhagia (HP:0000132) | 2.12033791 |
| 115 | Poikiloderma (HP:0001029) | 2.10981354 |
| 116 | Bone marrow hypocellularity (HP:0005528) | 2.10718925 |
| 117 | Anterior segment dysgenesis (HP:0007700) | 2.09738875 |
| 118 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09086864 |
| 119 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.08693030 |
| 120 | Neonatal onset (HP:0003623) | 2.06113971 |
| 121 | Cholelithiasis (HP:0001081) | 2.05823895 |
| 122 | Abnormality of the prostate (HP:0008775) | 2.04213303 |
| 123 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.02646599 |
| 124 | Papillary thyroid carcinoma (HP:0002895) | 2.02434275 |
| 125 | Vomiting (HP:0002013) | 2.01611873 |
| 126 | Abnormality of iron homeostasis (HP:0011031) | 2.00954946 |
| 127 | Poikilocytosis (HP:0004447) | 2.00568293 |
| 128 | Glomerulonephritis (HP:0000099) | 2.00019667 |
| 129 | Cerebral edema (HP:0002181) | 1.99617933 |
| 130 | Horseshoe kidney (HP:0000085) | 1.96802041 |
| 131 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.96700034 |
| 132 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.96700034 |
| 133 | Abnormal protein glycosylation (HP:0012346) | 1.96700034 |
| 134 | Abnormal glycosylation (HP:0012345) | 1.96700034 |
| 135 | Absent thumb (HP:0009777) | 1.96685552 |
| 136 | Elevated hepatic transaminases (HP:0002910) | 1.95745375 |
| 137 | Hemorrhage of the eye (HP:0011885) | 1.95277079 |
| 138 | Type I transferrin isoform profile (HP:0003642) | 1.93999761 |
| 139 | Encephalitis (HP:0002383) | 1.93816268 |
| 140 | Renal cortical cysts (HP:0000803) | 1.93667983 |
| 141 | Nausea (HP:0002018) | 1.93513458 |
| 142 | Enlarged kidneys (HP:0000105) | 1.91729577 |
| 143 | Sensorimotor neuropathy (HP:0007141) | 1.90486379 |
| 144 | Loss of speech (HP:0002371) | 1.90124697 |
| 145 | Pancytopenia (HP:0001876) | 1.90074407 |
| 146 | Gingival bleeding (HP:0000225) | 1.88584931 |
| 147 | Vascular calcification (HP:0004934) | 1.88086631 |
| 148 | Capillary hemangiomas (HP:0005306) | 1.87500646 |
| 149 | Insulin resistance (HP:0000855) | 1.87494296 |
| 150 | Thrombophlebitis (HP:0004418) | 1.87102595 |
| 151 | Hyperuricemia (HP:0002149) | 1.85857222 |
| 152 | Increased purine levels (HP:0004368) | 1.85857222 |
| 153 | Lymphopenia (HP:0001888) | 1.85276129 |
| 154 | Azoospermia (HP:0000027) | 1.85249266 |
| 155 | Limb hypertonia (HP:0002509) | 1.85113826 |
| 156 | Mitral stenosis (HP:0001718) | 1.84970654 |
| 157 | Proximal tubulopathy (HP:0000114) | 1.84791309 |
| 158 | Abnormality of the gallbladder (HP:0005264) | 1.84742148 |
| 159 | Agammaglobulinemia (HP:0004432) | 1.84468743 |
| 160 | Abnormal cartilage morphology (HP:0002763) | 1.83153984 |
| 161 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82551730 |
| 162 | Acute hepatic failure (HP:0006554) | 1.82495220 |
| 163 | Supernumerary spleens (HP:0009799) | 1.81730454 |
| 164 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81008505 |
| 165 | Progressive microcephaly (HP:0000253) | 1.80723082 |
| 166 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80370107 |
| 167 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.79182695 |
| 168 | Glycosuria (HP:0003076) | 1.78826028 |
| 169 | Abnormality of urine glucose concentration (HP:0011016) | 1.78826028 |
| 170 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.78435862 |
| 171 | Reduced antithrombin III activity (HP:0001976) | 1.77680983 |
| 172 | Leukopenia (HP:0001882) | 1.77381728 |
| 173 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.76157939 |
| 174 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.76157939 |
| 175 | Oligodactyly (hands) (HP:0001180) | 1.74794366 |
| 176 | Sloping forehead (HP:0000340) | 1.73348655 |
| 177 | Attenuation of retinal blood vessels (HP:0007843) | 1.71939105 |
| 178 | Colon cancer (HP:0003003) | 1.70283521 |
| 179 | Lissencephaly (HP:0001339) | 1.69869460 |
| 180 | Male infertility (HP:0003251) | 1.69167204 |
| 181 | Recurrent fungal infections (HP:0002841) | 1.69127277 |
| 182 | Pendular nystagmus (HP:0012043) | 1.67450792 |
| 183 | Heterotopia (HP:0002282) | 1.67139625 |
| 184 | Neurodegeneration (HP:0002180) | 1.66489745 |
| 185 | Abnormal spermatogenesis (HP:0008669) | 1.66386786 |
| 186 | Cleft eyelid (HP:0000625) | 1.66196791 |
| 187 | Hypoplasia of the thymus (HP:0000778) | 1.64981467 |
| 188 | Prostate neoplasm (HP:0100787) | 1.61126937 |
| 189 | Abnormal biliary tract physiology (HP:0012439) | 1.60703517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.37211521 |
| 2 | ERN1 | 4.99055761 |
| 3 | MAP4K2 | 4.17816606 |
| 4 | CDK19 | 3.98650347 |
| 5 | INSRR | 3.19442976 |
| 6 | FLT3 | 3.06025196 |
| 7 | FGFR4 | 2.88046093 |
| 8 | SIK1 | 2.78236221 |
| 9 | PKN2 | 2.73950197 |
| 10 | TRIB3 | 2.63196978 |
| 11 | TRIM28 | 2.59333196 |
| 12 | TAOK3 | 2.46937599 |
| 13 | MAP3K13 | 2.33706081 |
| 14 | MAPK15 | 2.30988017 |
| 15 | ZAK | 2.14856199 |
| 16 | KDR | 2.06316618 |
| 17 | PNCK | 2.02782298 |
| 18 | TTK | 1.98130990 |
| 19 | ARAF | 1.93806638 |
| 20 | RAF1 | 1.85978333 |
| 21 | NUAK1 | 1.83294825 |
| 22 | TNK2 | 1.80399737 |
| 23 | PIK3CG | 1.72784411 |
| 24 | MAP3K4 | 1.71762578 |
| 25 | MAP3K9 | 1.70760224 |
| 26 | EIF2AK3 | 1.64033477 |
| 27 | KSR2 | 1.63029473 |
| 28 | TYK2 | 1.62019019 |
| 29 | FRK | 1.58712842 |
| 30 | CDK9 | 1.56655881 |
| 31 | PTK6 | 1.55151029 |
| 32 | BRAF | 1.54317221 |
| 33 | STK24 | 1.50435895 |
| 34 | MAPK11 | 1.46490842 |
| 35 | ZAP70 | 1.40092405 |
| 36 | AURKA | 1.39950189 |
| 37 | PASK | 1.38786459 |
| 38 | MAP2K3 | 1.34645779 |
| 39 | IRAK3 | 1.32981612 |
| 40 | CDC7 | 1.28842704 |
| 41 | MAP4K1 | 1.28287735 |
| 42 | CDK8 | 1.26294255 |
| 43 | MAP3K10 | 1.23542390 |
| 44 | EEF2K | 1.21908781 |
| 45 | TXK | 1.21424102 |
| 46 | LATS1 | 1.16271460 |
| 47 | MAP2K7 | 1.15258301 |
| 48 | RIPK1 | 1.15177155 |
| 49 | TGFBR2 | 1.15044807 |
| 50 | CSNK1G3 | 1.14289681 |
| 51 | DYRK1B | 1.13793488 |
| 52 | PLK1 | 1.10897315 |
| 53 | MAPKAPK3 | 1.10174258 |
| 54 | MAP3K11 | 1.09230657 |
| 55 | TBK1 | 1.08766590 |
| 56 | TESK2 | 1.03828798 |
| 57 | BTK | 0.98813403 |
| 58 | SRPK1 | 0.98144111 |
| 59 | TIE1 | 0.97870205 |
| 60 | SCYL2 | 0.96003210 |
| 61 | TGFBR1 | 0.95824416 |
| 62 | MAP2K2 | 0.95350574 |
| 63 | CCNB1 | 0.95007958 |
| 64 | GRK6 | 0.93513669 |
| 65 | JAK2 | 0.92603913 |
| 66 | MST1R | 0.92482139 |
| 67 | CSNK1A1L | 0.89729933 |
| 68 | EIF2AK1 | 0.88842330 |
| 69 | RIPK4 | 0.88528846 |
| 70 | CDK4 | 0.87588473 |
| 71 | CDK3 | 0.86384455 |
| 72 | CDK6 | 0.85849063 |
| 73 | SYK | 0.84227653 |
| 74 | NEK9 | 0.82555829 |
| 75 | CSNK1G2 | 0.80180260 |
| 76 | BUB1 | 0.79710918 |
| 77 | TAOK1 | 0.78745172 |
| 78 | RPS6KB2 | 0.77467932 |
| 79 | CSNK1G1 | 0.76832924 |
| 80 | CAMK1D | 0.73805311 |
| 81 | PIM2 | 0.73478659 |
| 82 | TEC | 0.73460765 |
| 83 | CAMK1G | 0.73356338 |
| 84 | MARK3 | 0.73007531 |
| 85 | BCR | 0.71700019 |
| 86 | ACVR1B | 0.71392180 |
| 87 | ERBB4 | 0.71067831 |
| 88 | KSR1 | 0.68796299 |
| 89 | IRAK1 | 0.67332125 |
| 90 | ITK | 0.67191123 |
| 91 | IKBKE | 0.66694232 |
| 92 | EPHA2 | 0.66096202 |
| 93 | STK10 | 0.65714021 |
| 94 | IRAK2 | 0.65516808 |
| 95 | MTOR | 0.65152872 |
| 96 | STK16 | 0.65033339 |
| 97 | NLK | 0.63291386 |
| 98 | CHEK2 | 0.63283748 |
| 99 | MELK | 0.62798961 |
| 100 | HCK | 0.62769490 |
| 101 | ATM | 0.62580608 |
| 102 | JAK3 | 0.62480290 |
| 103 | VRK1 | 0.61845056 |
| 104 | MAP2K6 | 0.60311825 |
| 105 | PIM1 | 0.59861980 |
| 106 | CSK | 0.59627599 |
| 107 | BRSK2 | 0.59136894 |
| 108 | LCK | 0.58855341 |
| 109 | MAP2K4 | 0.58564806 |
| 110 | MAP3K3 | 0.58486238 |
| 111 | PDGFRA | 0.58230914 |
| 112 | CHEK1 | 0.57731111 |
| 113 | DYRK3 | 0.57268663 |
| 114 | PRKAA2 | 0.55730776 |
| 115 | MET | 0.53620657 |
| 116 | TAOK2 | 0.53022502 |
| 117 | EPHA3 | 0.51617158 |
| 118 | PTK2 | 0.51499868 |
| 119 | NEK2 | 0.51002400 |
| 120 | KIT | 0.49007963 |
| 121 | BRSK1 | 0.47796818 |
| 122 | LRRK2 | 0.46850251 |
| 123 | NME2 | 0.46298993 |
| 124 | PLK4 | 0.46034424 |
| 125 | CDK2 | 0.45905483 |
| 126 | LYN | 0.45071754 |
| 127 | STK38 | 0.44370596 |
| 128 | MAPK4 | 0.44248951 |
| 129 | PRKCQ | 0.44248568 |
| 130 | JAK1 | 0.44155086 |
| 131 | ABL2 | 0.43504513 |
| 132 | CDK7 | 0.43204482 |
| 133 | MAP3K1 | 0.43050255 |
| 134 | CSF1R | 0.42844854 |
| 135 | IRAK4 | 0.42559427 |
| 136 | MAP3K7 | 0.42514268 |
| 137 | RPS6KA4 | 0.42389790 |
| 138 | MAP3K8 | 0.42235706 |
| 139 | ICK | 0.41536075 |
| 140 | PRKAA1 | 0.40511554 |
| 141 | VRK2 | 0.39709923 |
| 142 | PRKD2 | 0.39654082 |
| 143 | STK4 | 0.39598709 |
| 144 | CHUK | 0.38940307 |
| 145 | ERBB2 | 0.38591974 |
| 146 | CDK1 | 0.36811357 |
| 147 | MAP2K1 | 0.36646493 |
| 148 | MAPK7 | 0.33281152 |
| 149 | GRK1 | 0.32885620 |
| 150 | CDC42BPA | 0.32369532 |
| 151 | HIPK2 | 0.32329675 |
| 152 | IGF1R | 0.32258314 |
| 153 | MAP3K5 | 0.31564105 |
| 154 | MAPK3 | 0.30527980 |
| 155 | PINK1 | 0.29913560 |
| 156 | BRD4 | 0.28703635 |
| 157 | PRKACG | 0.27145510 |
| 158 | CDK12 | 0.25168996 |
| 159 | AURKB | 0.24095739 |
| 160 | ATR | 0.23634648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.01471975 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.59493865 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.50870892 |
| 4 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 3.34048185 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.19849519 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 3.08794226 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87285957 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.81869984 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.65767899 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62787769 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59959983 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.59435577 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.57689913 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55958489 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54364631 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.54123816 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.38058901 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36063015 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.30217423 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22913624 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 2.21196739 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.20701806 |
| 23 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 2.16678613 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 2.16087815 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09837065 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99302360 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.98545645 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.97426598 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.94072880 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.89429072 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88825057 |
| 32 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.81075636 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80353191 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79214310 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.78927282 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.76141294 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73293581 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68611435 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68465933 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67664747 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.67185024 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.65273278 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64642129 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62787989 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59260868 |
| 46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.57829659 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55642680 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52113982 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 1.48177960 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.47950792 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46832013 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45925317 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45513935 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40776915 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39147061 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38324482 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.38162033 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36561937 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36094680 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.34948254 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33991249 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.30250450 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28816681 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.27788528 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 1.27383118 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.24503788 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.24315532 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 1.23032812 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.22422558 |
| 70 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.19650067 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19255883 |
| 72 | Spliceosome_Homo sapiens_hsa03040 | 1.17837153 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 1.15105570 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.14791360 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.14688154 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13667895 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 1.04453381 |
| 78 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.04353159 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.02660655 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01046375 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00862370 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98491864 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97313003 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96224655 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.95851172 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91573342 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88505569 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88018946 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82605800 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82201201 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80264288 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79984115 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79331542 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74045623 |
| 95 | Phototransduction_Homo sapiens_hsa04744 | 0.72701395 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.71334455 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71205133 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69076988 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68593166 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66571368 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65632491 |
| 102 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64367098 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.64028606 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63159707 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62735296 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60953486 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60314067 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60064990 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59974259 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58903985 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58256819 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56533188 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56216320 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55909588 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.55812398 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54610506 |
| 117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54064747 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53636109 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52541089 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48723546 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45721676 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43778478 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.42861350 |
| 124 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41965070 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38152577 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38020285 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35774069 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35744394 |
| 129 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.34719769 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34123104 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33405387 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32495214 |
| 133 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31110318 |
| 134 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30242325 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.26573187 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.26327479 |
| 137 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.26149584 |
| 138 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.26080103 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25475004 |
| 140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25149796 |
| 141 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23686925 |
| 142 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23027991 |
| 143 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.22720345 |
| 144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20561259 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18469562 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16692037 |
| 147 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16654039 |
| 148 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.15611844 |
| 149 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14617202 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14530423 |
| 151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14118784 |
| 152 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.12720258 |
| 153 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.11699348 |
| 154 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.10303721 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01798551 |
| 156 | Legionellosis_Homo sapiens_hsa05134 | 0.01362275 |
| 157 | Bladder cancer_Homo sapiens_hsa05219 | -0.0820308 |
| 158 | Base excision repair_Homo sapiens_hsa03410 | -0.0812797 |
| 159 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0709225 |
| 160 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.0633314 |
| 161 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0471476 |
| 162 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0350782 |
| 163 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0329303 |

